Indeed Snapshot

Track Nektar Therapeutics reviews on Indeed to uncover insights on employee sentiment
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Sector Industry
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Sep 6th, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Sep 6th, 2021 07:53AM Sep 6th, 2021 07:53AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Sep 5th, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Sep 5th, 2021 08:41AM Sep 5th, 2021 08:41AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Sep 3rd, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Sep 3rd, 2021 08:33AM Sep 3rd, 2021 08:33AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Sep 2nd, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Sep 2nd, 2021 05:54AM Sep 2nd, 2021 05:54AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Sep 1st, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Sep 1st, 2021 07:32AM Sep 1st, 2021 07:32AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Aug 30th, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Aug 30th, 2021 07:10AM Aug 30th, 2021 07:10AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Aug 29th, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Aug 29th, 2021 07:20AM Aug 29th, 2021 07:20AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Aug 28th, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Aug 28th, 2021 07:16AM Aug 28th, 2021 07:16AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Aug 27th, 2021 12:00AM Open Nektar Therapeutics Pharmaceutical & Biotechnology Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Aug 27th, 2021 07:18AM Aug 27th, 2021 07:18AM Health Care Pharmaceuticals & Biotechnology
nasdaq:nktr https://www.indeed.com/cmp/nektar-therapeutics Aug 26th, 2021 12:00AM Open Nektar Therapeutics Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. RRv1_100M_500M Howard W. Robin 3.70 42.00 42.00 3.40 4.00 3.00 3.20 3.80 8.00 About a week 9.00 MEDIUM 9.00 FAVORABLE Aug 26th, 2021 06:24AM Aug 26th, 2021 06:24AM Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.